PokeAcell is an immunotherapy company with a proprietary technology for personalized T cell therapy of late stage cancer. PokeAcells proprietary technology activate and grow cancer-specific T cells present in patient’s own blood and the cells are given back to the patient as fully personalized treatment. The T cell therapy hold the promise of curative treatment in Metastatic Melanoma and Merkel Cell carcinoma – two of the most severe skin cancers today and with potential in several other indications.
Company Details
- Founded
- 2020
- Address
- Copenhagen, Dk
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- pokeacell.com
- HQ
- Copenhagen
Pokeacell Questions
Pokeacell's website is pokeacell.com
Pokeacell's LinkedIn profile is https://dk.linkedin.com/company/pokeacell
Pokeacell's industry is
Pharmaceutical Manufacturing
Pokeacell's top competitors are
Glycorex Transplantation Ab (Publ),
Pancryos,
Xy Therapeutics,
Novo Nordisk,
2l Projektudvikling A/s,
Blue Cell Therapeutics,
Fosgerau Consult Aps,
Tomorrow Projects,
Cymab,
Pephexia Therapeutics Aps.
Pokeacell's categories are Pharmaceutical Manufacturing
Pokeacell's founding year is 2020
